These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7557496

  • 1. Effectiveness of immunotherapy in aged leukemic mice.
    Dussault I, Miller SC.
    Gerontology; 1995; 41(4):195-204. PubMed ID: 7557496
    [Abstract] [Full Text] [Related]

  • 2. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
    Christopher FL, Dussault I, Miller SC.
    Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I, Miller SC.
    Nat Immun; 1993 Dec; 12(2):66-78. PubMed ID: 8318817
    [Abstract] [Full Text] [Related]

  • 4. Effect on leukemia cell numbers of in vivo administration of immunotherapeutic agents is age-dependent.
    Dussault I, Miller SC.
    Oncology; 1996 Dec; 53(3):241-6. PubMed ID: 8643228
    [Abstract] [Full Text] [Related]

  • 5. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin.
    Miller SC, Christopher FL, Dussault I.
    Nat Immun; 1992 Dec; 11(2):78-91. PubMed ID: 1498521
    [Abstract] [Full Text] [Related]

  • 6. Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span.
    Currier NL, Miller SC.
    J Altern Complement Med; 2001 Jun; 7(3):241-51. PubMed ID: 11439845
    [Abstract] [Full Text] [Related]

  • 7. Decline in natural killer cell-mediated immunosurveillance in aging mice--a consequence of reduced cell production and tumor binding capacity.
    Dussault I, Miller SC.
    Mech Ageing Dev; 1994 Aug; 75(2):115-29. PubMed ID: 7823634
    [Abstract] [Full Text] [Related]

  • 8. The effect of immunization with killed tumor cells, with/without feeding of Echinacea purpurea in an erythroleukemic mouse model.
    Currier NL, Miller SC.
    J Altern Complement Med; 2002 Feb; 8(1):49-58. PubMed ID: 11890433
    [Abstract] [Full Text] [Related]

  • 9. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
    Saarloos MN, Khoo NK, Lala PK.
    Cancer Res; 1992 Dec 01; 52(23):6452-62. PubMed ID: 1423293
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R, Wei H, Zhang J, Li A, Zhang W, Tian Z.
    Neuroimmunomodulation; 1992 Dec 01; 10(3):169-76. PubMed ID: 12481157
    [Abstract] [Full Text] [Related]

  • 11. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2.
    Parhar RS, Lala PK.
    J Exp Med; 1987 Jan 01; 165(1):14-28. PubMed ID: 3491867
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
    Khoo NK, Chan FP, Saarloos MN, Lala PK.
    Clin Exp Metastasis; 1992 Jul 01; 10(4):239-52. PubMed ID: 1617832
    [Abstract] [Full Text] [Related]

  • 13. Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice.
    Johnson CS, Thurlow SM, Furmanski P.
    Leukemia; 1989 Feb 01; 3(2):91-6. PubMed ID: 2783472
    [Abstract] [Full Text] [Related]

  • 14. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.
    Mulé JJ, Ettinghausen SE, Spiess PJ, Shu S, Rosenberg SA.
    Cancer Res; 1986 Feb 01; 46(2):676-83. PubMed ID: 3484431
    [Abstract] [Full Text] [Related]

  • 15. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ, Yang J, Shu S, Rosenberg SA.
    J Immunol; 1986 May 15; 136(10):3899-909. PubMed ID: 2871106
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    Hornung RL, Back TC, Zaharko DS, Urba WJ, Longo DL, Wiltrout RH.
    J Immunol; 1988 Nov 15; 141(10):3671-9. PubMed ID: 2460546
    [Abstract] [Full Text] [Related]

  • 17. Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated.
    Currier NL, Miller SC.
    Exp Gerontol; 2000 Aug 15; 35(5):627-39. PubMed ID: 10978684
    [Abstract] [Full Text] [Related]

  • 18. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
    Papa MZ, Mulé JJ, Rosenberg SA.
    Cancer Res; 1986 Oct 15; 46(10):4973-8. PubMed ID: 3489517
    [Abstract] [Full Text] [Related]

  • 19. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
    Lala PK, Parhar RS, Singh P.
    Cell Immunol; 1986 Apr 15; 99(1):108-18. PubMed ID: 2944621
    [Abstract] [Full Text] [Related]

  • 20. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.